NO20051155L - Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse - Google Patents
Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelseInfo
- Publication number
- NO20051155L NO20051155L NO20051155A NO20051155A NO20051155L NO 20051155 L NO20051155 L NO 20051155L NO 20051155 A NO20051155 A NO 20051155A NO 20051155 A NO20051155 A NO 20051155A NO 20051155 L NO20051155 L NO 20051155L
- Authority
- NO
- Norway
- Prior art keywords
- give
- rizatriptan
- reaction
- preparation
- hydrazone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200201874A ES2204303B2 (es) | 2002-08-07 | 2002-08-07 | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
PCT/IB2003/003540 WO2004014877A1 (en) | 2002-08-07 | 2003-08-05 | Process for preparing rizatriptan |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051155L true NO20051155L (no) | 2005-03-03 |
Family
ID=31502894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051155A NO20051155L (no) | 2002-08-07 | 2005-03-03 | Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse |
Country Status (11)
Country | Link |
---|---|
US (1) | US7279581B2 (es) |
EP (1) | EP1527053B8 (es) |
KR (1) | KR20050039749A (es) |
AT (1) | ATE312084T1 (es) |
AU (1) | AU2003250478A1 (es) |
DE (1) | DE60302671D1 (es) |
ES (2) | ES2204303B2 (es) |
IS (1) | IS7702A (es) |
NO (1) | NO20051155L (es) |
TW (1) | TW200404798A (es) |
WO (1) | WO2004014877A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1678305A (zh) * | 2002-06-27 | 2005-10-05 | Sb药物波多黎各公司 | 卡维地洛磷酸盐和/或其溶剂合物和/或相应组合物和/或治疗方法 |
ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
US7777049B2 (en) | 2004-01-09 | 2010-08-17 | Ratiopharm Gmbh | Crystalline forms of Rizatriptan benzoate |
EP1751104B1 (en) * | 2004-01-28 | 2010-03-24 | ratiopharm GmbH | Synthesis methods and intermediates for the manufacture of rizatriptan |
WO2007054979A1 (en) * | 2005-11-14 | 2007-05-18 | Matrix Laboratories Ltd | Process for the large scale production of rizatriptan benzoate |
ATE510836T1 (de) * | 2006-01-19 | 2011-06-15 | Matrix Lab Ltd | Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin |
JP7126260B2 (ja) | 2016-01-27 | 2022-08-26 | インスター テクノロジーズ アクチオヴァ スプルチュノスト | 治療処置用の口腔粘膜ナノファイバ担体 |
CN115353492A (zh) * | 2022-08-26 | 2022-11-18 | 浙江野风药业股份有限公司 | 一种连续合成1-(4-肼基苯基)甲基-1,2,4-三氮唑的方法 |
CN115417859B (zh) * | 2022-09-19 | 2024-02-02 | 陕西师范大学 | 一种苯甲酸利扎曲坦的合成方法 |
CN116283924A (zh) * | 2023-01-16 | 2023-06-23 | 四川效佳科技有限公司 | 一种药用级纯度的苯甲酸利扎曲普坦的重结晶方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
ES2033578B1 (es) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida. |
ES2033577B1 (es) | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores. |
GB9215526D0 (en) * | 1992-07-22 | 1992-09-02 | Merck Sharp & Dohme | Chemical process |
US5567824A (en) * | 1994-05-24 | 1996-10-22 | Merck & Co., Inc. | Palladium catalyzed ring closure of triazolyltryptamine |
DE69717287T2 (de) | 1996-08-13 | 2003-09-11 | Merck & Co Inc | Palladiumkatalysierte indolisierung |
US5998438A (en) * | 1996-11-26 | 1999-12-07 | Allelix Biopharmaceuticals, Inc. | 5-cyclo indole compounds |
GB9926250D0 (en) | 1999-11-06 | 2000-01-12 | Knoll Ag | Chemical process |
-
2002
- 2002-08-07 ES ES200201874A patent/ES2204303B2/es not_active Expired - Fee Related
-
2003
- 2003-08-05 US US10/509,918 patent/US7279581B2/en active Active
- 2003-08-05 ES ES03784405T patent/ES2254982T3/es not_active Expired - Lifetime
- 2003-08-05 AU AU2003250478A patent/AU2003250478A1/en not_active Abandoned
- 2003-08-05 DE DE60302671T patent/DE60302671D1/de not_active Expired - Lifetime
- 2003-08-05 EP EP03784405A patent/EP1527053B8/en not_active Expired - Lifetime
- 2003-08-05 KR KR1020047012028A patent/KR20050039749A/ko not_active Application Discontinuation
- 2003-08-05 WO PCT/IB2003/003540 patent/WO2004014877A1/en not_active Application Discontinuation
- 2003-08-05 AT AT03784405T patent/ATE312084T1/de not_active IP Right Cessation
- 2003-08-05 TW TW092121365A patent/TW200404798A/zh unknown
-
2005
- 2005-02-21 IS IS7702A patent/IS7702A/is unknown
- 2005-03-03 NO NO20051155A patent/NO20051155L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW200404798A (en) | 2004-04-01 |
IS7702A (is) | 2005-02-21 |
EP1527053B8 (en) | 2006-03-08 |
DE60302671D1 (de) | 2006-01-12 |
ES2204303A1 (es) | 2004-04-16 |
US7279581B2 (en) | 2007-10-09 |
WO2004014877A1 (en) | 2004-02-19 |
AU2003250478A1 (en) | 2004-02-25 |
US20050148778A1 (en) | 2005-07-07 |
EP1527053B1 (en) | 2005-12-07 |
ES2254982T3 (es) | 2006-06-16 |
ES2204303B2 (es) | 2004-12-16 |
ATE312084T1 (de) | 2005-12-15 |
KR20050039749A (ko) | 2005-04-29 |
EP1527053A1 (en) | 2005-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051155L (no) | Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse | |
NO20051178L (no) | Fremgangsmate til fremstilling av zolmitriptanforbindelser | |
ES2197508T3 (es) | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y derivados. | |
DK172751B1 (da) | Cis,endo-2-azabicyclo[3,3,0]octan-3-carboxylsyrer og estere deraf samt salte deraf og fremgangsmåde til deres fremstilling | |
CY1112283T1 (el) | Μεθοδος για την παρασκευη 17-βινυλ-τριφλικων ως ενδιaμεσα | |
TNSN05140A1 (en) | Perindopril | |
NZ600767A (en) | Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives | |
CA2608627A1 (en) | Novel nsaids possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety | |
CY1109114T1 (el) | Βελτιωμενη μεθοδος διεργασιων για την παρασκευη ραμιπριλης | |
ES2185790T3 (es) | Sintesis en un solo recipiente de derivados de 2-oxazolidinona. | |
Janczuk et al. | Ytterbium triflate catalyzed electrophilic substitution of indoles: the synthesis of unnatural tryptophan derivatives | |
Pfefferkorn et al. | Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors | |
IL179871A0 (en) | Process for the preparation of gabapentin | |
Ma et al. | Efficient asymmetric synthesis of important tryptophan analogs for biological research via the Schöllkopf chiral auxiliary | |
ES2386989T3 (es) | Derivados de ácido fenilacético como inhibidores de COX-2 | |
AR026362A1 (es) | Procedimiento quimico | |
WO2008056378A3 (en) | Novel process for the preparation of naratriptan hydrochloride | |
Danchev et al. | Synthesis, acute toxicity, and analgesic activity of new derivatives of pyrrole | |
WO2009074524A3 (de) | Verfahren zur enzymatischen reduktion von alpha-dehydroaminosäuren unter verwendung von enoat dehydrogenasen | |
WO2004041781A8 (en) | Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones | |
EP1148783A4 (en) | CONVERSION OF COX INHIBITING, NON COX-2 SELECTIVE INHIBITORS TO DERIVATIVES OF COX-2 SELECTIVE INHIBITORS | |
Grigorenko et al. | A new synthesis of α-methylspermidine | |
García-Reynaga et al. | Biomimetic synthesis of Cbz-(S)-dolaphenine | |
AU2002345522A1 (en) | Process for the production of lisinopril | |
HUP0002109A2 (hu) | (E)-4,6-diklór-3-(2-oxo-1-fenilpirrolidin-3-ilidén-metil)-1H-indol-2-karbonsav kristályos hidratált nátriumsója, eljárás előállítására és az ilyen vegyületet tartalmazó gyógyszerkészítmény |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |